arXiv AI By Yesung Cho, Dongmyung Shin, Sujeong Hong, Jooyeon Lee, Seongmin Park, Geongyu Lee, Won Young Park, Bongjin Park, Jongbae Park, Hong Koo Ha

A Computationally Efficient Multi-Section Whole Slide Image Analysis for Capturing Prostate Cancer Multifocality in Biochemical Recurrence Prediction

Read the original on arXiv AI →

The study introduces a computationally efficient multi‑section whole slide image analysis framework that captures the entire prostate tumor landscape to predict biochemical recurrence (BCR) after radical prostatectomy. Using a large dataset of 23,451 slides from 789 patients, the authors optimized patch and slide subsampling to reduce computational demands while achieving strong predictive performance for 1‑ and 2‑year BCR, comparable to or better than existing clinical benchmarks. The AI‑derived risk score was an independent prognostic factor, improved prognostic performance when combined with clinical variables, and showed preliminary transferability in an external cohort, with attention‑dispersion analysis confirming that the model leveraged information from multiple sections consistent with prostate cancer’s multifocal nature.

Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at arXiv AI.

Hugging Face Trending Papers
Jul 15

TRACE-PCa: Predicting Prostate Cancer Progression from Longitudinal MRI During Active Surveillance

Active surveillance (AS) is the preferred strategy for favorable-risk prostate cancer, yet current protocols rely on scheduled repeat biopsies, most of which reveal no progression and are unnecessary. Existing risk-stratification tools operate on single time-point imaging or depend on explicit lesion segmentation, limiting their ability to capture longitudinal change and excluding patients without an MRI-visible lesion.

arXiv Computer Vision
Aug 25

CHIMERA Challenge: Biochemical Recurrence Prediction in Prostate Cancer Patients using multimodal datasets

arXiv:2608.21497v1 Announce Type: cross Abstract: Biochemical recurrence (BCR), defined as any detectable prostate-specific antigen level after prostatectomy with confirmatory elevation, is widely us...

By Robert N. Spaans, Catherine Chia, Tongjie Wang, Adam Kowalewski, Parandzem Khachatryan, Domingos Oliveira, Khrystyna Faryna, Jean-Paul A. van Basten, Geert Litjens, Nadieh Khalili
arXiv Machine Learning
Jul 9

Compass: Prostate Cancer Detection Needs Multi-View Context

arXiv:2607. 06919v1 Announce Type: cross Abstract: Artificial intelligence (AI) analysis of micro-ultrasound ($\mu$US) has shown promise for prostate cancer (PCa) detection.

By Paul F. R. Wilson, Mohamed Harmanani, Zhuoxin Guo, Obed K. Dzikunu, Hannes Cash, Adam Kinnaird, Brian Wodlinger, Purang Abolmaesumi, Parvin Mousavi
arXiv AI
1d ago

Multimodal Fusion Methods for Whole-Slide Images and Clinical Data in Inflammatory Bowel Disease

The paper introduces a modular framework for multimodal AI fusion that combines slide-level embeddings from histology images with per-visit clinical embeddings using 15 interchangeable fusion methods. Applied to a prospective cohort of newly diagnosed inflammatory bowel disease patients, the best fusion method achieved macro‑F1 scores between 0.57 and 0.75, outperforming single‑modality models in most scenarios and showing varying reliance on image data depending on the remission outcome. The study highlights how different fusion strategies can influence predictive performance across distinct clinical endpoints.

By Ankana Banerjee (University of Stavanger, Norway), Mark van der Giezen (University of Stavanger, Norway), Ole Gunnar Aasprong (Stavanger University Hospital, Norway), Emiel A. M. Janssen (University of Stavanger, Norway), {\O}yvind Steinsb{\o} (Stavanger University Hospital, Norway), Tore Grimstad (Stavanger University Hospital, Norway), Kjersti Engan (University of Stavanger, Norway)
arXiv AI
Aug 21

MambaX-Net: Dual-Input Mamba-Enhanced Cross-Attention Network for Longitudinal Prostate MRI Segmentation

arXiv:2510. 17529v3 Announce Type: replace-cross Abstract: Active Surveillance (AS) is a treatment option for managing low and intermediate-risk prostate cancer (PCa), aiming to avoid overtreatment while monitoring disease progression through serial MRI and clinical follow-up.

By Yovin Yahathugoda, Davide Prezzi, Patricia A. Gutierrez, Piyalitt Ittichaiwong, Vicky Goh, Sebastien Ourselin, Michela Antonelli